Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ628630,50,16
KB768771-0,77
PKN78,478,48-3,54
Msft-0,56
Nokia4,3364,3515-0,90
IBM-1,70
Daimler AG76,9877,01-3,00
PFE-1,70
19.06.2021 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 09.06.2021 8:01:49
DaVita (DVA.F, Frankfurt)
Závěr k 18.6.2021 Změna (%) Změna (EUR) Objem obchodů (EUR)
103,40 1,92 1,95 781
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 20.06.2021
Popis společnosti
Obecné informace
Název společnostiDavita Inc
TickerDVA
Kmenové akcie:Ordinary Shares
RICDVA
ISIN-
Poslední známé roční výsledky31.12.2020
Poslední známé čtvrtletní výsledky31.03.2021
Počet zaměstnanců k 31.12.2020 67 000
Akcie v oběhu k 26.04.2021 106 200 000
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice2000 16th St
MěstoDENVER
PSČ80202-5158
ZeměUnited States
Kontatní osobaJim Gustafson
Funkce kontaktní osobyVice President - Investor Relations
Telefon13 105 362 668
Fax13026365454
Kontatní telefon13 105 362 585

Business Summary: DaVita Inc., formerly DaVita HealthCare Partners Inc., operates one division: DaVita Kidney Care (Kidney Care). The Kidney Care division consists of the Company's United States dialysis and related lab services, its ancillary services and strategic initiatives, including its international operations, and its corporate administrative support. The Company's segments include U.S. dialysis and related lab services and Other-Ancillary services and strategic initiatives. Its U.S. dialysis and related lab services line of business provide kidney dialysis services in the United States for patients suffering from chronic kidney failure, also known as an end-stage renal disease (ESRD). In addition, as of March 31, 2019, the Company operated or provided administrative services to 243 outpatient dialysis centers located in nine countries outside of the United States.
Financial Summary: BRIEF: For the three months ended 31 March 2021, Davita Increvenues decreased 1% to $2.82B. Net income beforeextraordinary items increased 3% to $237.4M. Revenuesreflect U.S. dialysis segment decrease of 2% to $2.56B,Other—Ancillary services segment decrease of 1% to $257.1M.Basic Earnings per Share excluding Extraordinary Itemsincreased from $1.84 to $2.18.
Odvětvová klasifikace
TRBC2009Healthcare Facilities / Services
TRBC2012Healthcare Facilities & Services (NEC)
RBSS2004Healthcare Facilities
MGINDUSTRYHealthcare Facilities
MGSECTORHealthcare
NAICS2007Kidney Dialysis Centers
NAICS2007All Other Outpatient Care Centers
NAICS2007Medical Laboratories
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS2007All Oth Misc Ambulatory Health Care Services
NAICS1997Kidney Dialysis Centers
NAICS1997All Other Outpatient Care Centers
NAICS1997Medical Laboratories
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
NAICS1997All Other Miscellaneous Ambulatory Health Care Services
SICKidney Dialysis Centers
SICSpecialty Outpatient Clinics, Nec
SICMedical Laboratories
SICCommercial Physical Research
SICHealth And Allied Services, Nec



  • Poslední aktualizace: 20.06.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Independent Chairman of the BoardPamela Arway6701.06.202001.06.2020
Chief Executive Officer, DirectorJavier Rodriguez5001.06.2019
Chief Financial Officer, TreasurerJoel Ackerman5527.02.2017
Chief Accounting OfficerJohn Winstel5022.02.202028.10.2019
Chief Compliance OfficerJames Hearty52
Chief Operating Officer- DaVita Kidney CareMichael Staffieri47
Chief Legal and Public Affairs OfficerKathleen Waters53